Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $37.3 million.

  • Metagenomi's Shares Outstanding (Weighted Average) rose 158.61% to $37.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year increase of 158.61%. This contributed to the annual value of $33.0 million for FY2024, which is 87010.03% up from last year.
  • Latest data reveals that Metagenomi reported Shares Outstanding (Weighted Average) of $37.3 million as of Q3 2025, which was up 158.61% from $37.2 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Shares Outstanding (Weighted Average) registered a high of $37.3 million during Q3 2025, and its lowest value of $3.4 million during Q1 2023.
  • In the last 3 years, Metagenomi's Shares Outstanding (Weighted Average) had a median value of $33.0 million in 2024 and averaged $23.0 million.
  • Per our database at Business Quant, Metagenomi's Shares Outstanding (Weighted Average) surged by 97990.57% in 2024 and then skyrocketed by 145.17% in 2025.
  • Quarter analysis of 3 years shows Metagenomi's Shares Outstanding (Weighted Average) stood at $3.4 million in 2023, then skyrocketed by 870.1% to $33.0 million in 2024, then rose by 13.08% to $37.3 million in 2025.
  • Its last three reported values are $37.3 million in Q3 2025, $37.2 million for Q2 2025, and $37.0 million during Q1 2025.